Choueiri, T. K., Lee, J. L., Merchan, J. R., Patnaik, A., Garmezy, B., Drakaki, A., Ornstein, M. C., McGregor, B. A., Hauke, R. J., Tsao, K., Rini, B. I., Barata, P. C., Foster, P. G., Mukhopadhyay, S., Gupta, N., Chen, J., Monga, M., Nuyten, D. S. A., Rha, S. Y. (2025). Casdatifan (Cas) monotherapy in patients (pts) with previously treated clear cell renal cell carcinoma (ccRCC): Safety, efficacy and subgroup analysis across multiple doses from ARC-20, a phase 1 open-label study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.441